Physics

A.D. Martin, W.J. Stirling, R.G. Roberts, "New information on parton distributions," Physical Review D, 47:867-82, 1993. Alan D. Martin (Centre for Particle Theory, University of Durham, England): "The use of energetic electrons (and other leptons) to probe the structure of the proton has had a long and successful history. These so-called deep-inelastic experiments have shown that the proton is composed of quark and gluon constitue


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A.D. Martin, W.J. Stirling, R.G. Roberts, "New information on parton distributions," Physical Review D, 47:867-82, 1993.

Alan D. Martin (Centre for Particle Theory, University of Durham, England): "The use of energetic electrons (and other leptons) to probe the structure of the proton has had a long and successful history. These so-called deep-inelastic experiments have shown that the proton is composed of quark and gluon constituents--the more energetic the bombarding electron, the better its resolution and the more partons (quarks and gluons) that are `seen.' Parton distributions describe how the proton's energy is shared among its quark and gluon constituents. By measuring these distributions we can learn about how quarks and gluons interact, and test the theory of the strong interaction.

"In any high-energy collision involving the proton, the interaction takes place at the partonic level. That is, in a collision the proton delivers only part of its energy, since the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio